We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Strumming his pain

6 February 2020 By Richard Beales

It’s logical Paul Singer’s activist firm should take a swipe at Masayoshi Son’s undervalued $90 bln empire. Debt, bold – or foolhardy – tech investments like WeWork, and one man’s concentrated influence all make SoftBank a target. It’s a test of the scope to rein in a visionary.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)